Encephalitozoon cuniculi Genotype II Concentrates in Inflammation Foci

Klára Brdíčková1,2, Bohumil Sak3, Nikola Holubová3,4

  • 1Department of Clinical Microbiology, Bulovka Hospital, Prague, Czech Republic.

Abstract

Insights

Inflammation can trigger the spread of Encephalitozoon cuniculi (E. cuniculi) genotype II in both immunocompetent and immunodeficient mice. This suggests immune cells may transport the parasite, highlighting microsporidia

Area of Science:

  • Parasitology
  • Immunology
  • Microbiology

Background:

  • Microsporidia, particularly Encephalitozoon species, cause severe, often fatal, infections in immunodeficient individuals.
  • In immunocompetent hosts, infections are typically mild, with the alimentary tract as a primary site, but systemic spread mechanisms are poorly understood.

Purpose of the Study:

  • To investigate the relationship between induced inflammation and the dissemination of Encephalitozoon cuniculi (E. cuniculi) genotype II in mice.
  • To determine if inflammation influences parasite presence in various organs and fecal samples in different immune states.

Main Methods:

  • Utilized molecular and histological techniques to detect E. cuniculi genotype II spores.
  • Infected both immunocompetent (BALB/c) and immunodeficient (SCID) mice.
  • Induced inflammation in infected mice to observe its effect on parasite distribution.

Main Results:

  • Demonstrated a positive correlation between induced inflammation and increased E. cuniculi genotype II occurrence at inflammation sites in both mouse models.
  • Observed reactivation of latent E. cuniculi infections in immunocompetent mice following inflammation induction.
  • Confirmed parasite presence in selected organs and fecal specimens.

Conclusions:

  • Results suggest immune cells may act as carriers for E. cuniculi genotype II, facilitating its transport to inflammatory sites.
  • Recommends reconsidering microsporidia as potential agents in diverse pathologies.
  • Emphasizes the need to understand the link between pro-inflammatory responses and microsporidiosis for human health and therapeutic development.